{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:07:43Z","timestamp":1784200063344,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02309-5","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:09:31Z","timestamp":1784196571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial-mesenchymal transition is associated with altered immune composition and cytotoxic function in triple-negative breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Hanxu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisam","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred W.","family":"Kolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A.","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar R.","family":"Pattabiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2309_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0080-4","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019. https:\/\/doi.org\/10.1038\/s41580-018-0080-4.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2309_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39104","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009. https:\/\/doi.org\/10.1172\/JCI39104.","journal-title":"J Clin Invest"},{"key":"2309_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001.","journal-title":"Trends Cell Biol"},{"key":"2309_CR4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1812876116","author":"C Kr\u00f6ger","year":"2019","unstructured":"Kr\u00f6ger C, Afeyan A, Mraz J, Eaton EN, Reinhardt F, Khodor YL, et al. Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc Natl Acad Sci USA. 2019. https:\/\/doi.org\/10.1073\/pnas.1812876116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2309_CR5","doi-asserted-by":"crossref","unstructured":"Brown MS, Abdollahi B, Wilkins OM, Lu H, Chakraborty P, Ognjenovic NB, et al. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [Internet]. Sci Adv. 2022;8. Available from: https:\/\/www.science.org","DOI":"10.1126\/sciadv.abj8002"},{"key":"2309_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01347-8","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022. https:\/\/doi.org\/10.1186\/s13045-022-01347-8.","journal-title":"J Hematol Oncol"},{"key":"2309_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111561","author":"D Sinha","year":"2020","unstructured":"Sinha D, Saha P, Samanta A, Bishayee A. Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10111561.","journal-title":"Biomolecules"},{"key":"2309_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvy047","author":"M Saitoh","year":"2018","unstructured":"Saitoh M. Involvement of partial EMT in cancer progression. J Biochem. 2018. https:\/\/doi.org\/10.1093\/jb\/mvy047.","journal-title":"J Biochem"},{"key":"2309_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12093","author":"S Terry","year":"2017","unstructured":"Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, et al. New insights into the role of EMT in tumor immune escape. Mol Oncol. 2017. https:\/\/doi.org\/10.1002\/1878-0261.12093.","journal-title":"Mol Oncol"},{"key":"2309_CR10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4459","author":"M Taki","year":"2021","unstructured":"Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, et al. Tumor immune microenvironment during epithelial- mesenchymal transition. Clin Cancer Res. 2021. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4459.","journal-title":"Clin Cancer Res"},{"key":"2309_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01767-y","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024. https:\/\/doi.org\/10.1038\/s41587-023-01767-y.","journal-title":"Nat Biotechnol"},{"key":"2309_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019. https:\/\/doi.org\/10.1038\/s41590-018-0276-y.","journal-title":"Nat Immunol"},{"key":"2309_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ni1008-1091","author":"TSP Heng","year":"2008","unstructured":"Heng TSP, Painter MW, Elpek K, Lukacs-Kornek V, Mauermann N, Turley SJ, et al. The immunological genome project: networks of gene expression in immune cells. Nat Immunol. 2008. https:\/\/doi.org\/10.1038\/ni1008-1091.","journal-title":"Nat Immunol"},{"key":"2309_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254257","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014. https:\/\/doi.org\/10.1126\/science.1254257.","journal-title":"Science"},{"key":"2309_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0501","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016. https:\/\/doi.org\/10.1126\/science.aad0501.","journal-title":"Science"},{"key":"2309_CR16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1558","author":"LA Byers","year":"2013","unstructured":"Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1558.","journal-title":"Clin Cancer Res"},{"key":"2309_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00220","author":"P Chakraborty","year":"2020","unstructured":"Chakraborty P, George JT, Tripathi S, Levine H, Jolly MK. Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum. Front Bioeng Biotechnol. 2020. https:\/\/doi.org\/10.3389\/fbioe.2020.00220.","journal-title":"Front Bioeng Biotechnol"},{"key":"2309_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404208","author":"TZ Tan","year":"2014","unstructured":"Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, et al. Epithelial\u2010mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014. https:\/\/doi.org\/10.15252\/emmm.201404208.","journal-title":"EMBO Mol Med"},{"key":"2309_CR19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3521","author":"JT George","year":"2017","unstructured":"George JT, Jolly MK, Xu S, Somarelli JA, Levine H. Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Res. 2017. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3521.","journal-title":"Cancer Res"},{"key":"2309_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab804","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Wong CJ, Yang L, Ouardaoui N, Li D, Zhang W, et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 2022. https:\/\/doi.org\/10.1093\/nar\/gkab804.","journal-title":"Nucleic Acids Res"},{"key":"2309_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2014.02.025","author":"C Fiorentini","year":"2014","unstructured":"Fiorentini C, Bodei S, Bedussi F, Fragni M, Bonini SA, Simeone C, et al. GPNMB\/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. Exp Cell Res. 2014. https:\/\/doi.org\/10.1016\/j.yexcr.2014.02.025.","journal-title":"Exp Cell Res"},{"key":"2309_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674739","author":"M Saade","year":"2021","unstructured":"Saade M, Araujo de Souza G, Scavone C, Kinoshita PF. The role of GPNMB in inflammation. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.674739.","journal-title":"Front Immunol"},{"key":"2309_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15331","author":"Y Sakano","year":"2022","unstructured":"Sakano Y, Noda T, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, et al. Tumor endothelial cell-induced CD8+ T-cell exhaustion via GPNMB in hepatocellular carcinoma. Cancer Sci. 2022. https:\/\/doi.org\/10.1111\/cas.15331.","journal-title":"Cancer Sci"},{"key":"2309_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgy095","author":"J Rem\u0161\u00edk","year":"2018","unstructured":"Rem\u0161\u00edk J, Bin\u00f3 L, Kahounov\u00e1 Z, Kharaishvili G, \u0160ime\u010dkov\u00e1 \u0160, Fedr R, et al. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition. Carcinogenesis. 2018. https:\/\/doi.org\/10.1093\/carcin\/bgy095.","journal-title":"Carcinogenesis"},{"issue":"2","key":"2309_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3892\/or.2018.6496","volume":"40","author":"W Zhao","year":"2018","unstructured":"Zhao W, Kuai X, Zhou X, Jia L, Wang J, Yang X, et al. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer. Oncol Rep. 2018. https:\/\/doi.org\/10.3892\/or.2018.6496.","journal-title":"Oncol Rep"},{"issue":"1","key":"2309_CR26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41419-025-07615-y","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, Cen Y, Qian K, Yang W, Zhou W, Yang Y. MMP1-induced NF-\u03baB activation promotes epithelial\u2013mesenchymal transition and sacituzumab govitecan resistance in hormone receptor-positive breast cancer. Cell Death Dis. 2025. https:\/\/doi.org\/10.1038\/s41419-025-07615-y.","journal-title":"Cell Death Dis"},{"key":"2309_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0223-7","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-019-0223-7.","journal-title":"Nat Rev Immunol"},{"key":"2309_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.021","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider DT, Charmoy M, Chennupati V, Pousse L, Ferreira DP, Calderon-Copete S, et al. T Cell Factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity. 2016. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.021.","journal-title":"Immunity"},{"key":"2309_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.014","author":"JC Beltra","year":"2020","unstructured":"Beltra JC, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity. 2020. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.014.","journal-title":"Immunity"},{"key":"2309_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.11.004","author":"Y Chien","year":"2013","unstructured":"Chien Y, Zeng X, Prinz I. The natural and the inducible: interleukin (IL)-17-producing \u03b3\u03b4 T cells. Trends Immunol. 2013. https:\/\/doi.org\/10.1016\/j.it.2012.11.004.","journal-title":"Trends Immunol"},{"key":"2309_CR31","doi-asserted-by":"publisher","DOI":"10.4161\/onci.1.1.17995","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2012","unstructured":"Gonz\u00e1lez-Mart\u00edn A, Mira E, Ma\u00f1es S. CCR5 in cancer immunotherapy: more than an \u2018attractive\u2019 receptor for T cells. OncoImmunology. 2012. https:\/\/doi.org\/10.4161\/onci.1.1.17995.","journal-title":"OncoImmunology"},{"key":"2309_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02395","author":"PY Chen","year":"2019","unstructured":"Chen PY, Wu CYJ, Fang JH, Chen HC, Feng LY, Huang CY, et al. Functional change of effector tumor-infiltrating CCR5+CD38+HLA-DR+CD8+ T cells in glioma microenvironment. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.02395.","journal-title":"Front Immunol"},{"key":"2309_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003100","author":"B Wang","year":"2021","unstructured":"Wang B, Wang Y, Sun X, Deng G, Huang W, Wu X, et al. CXCR6 is required for antitumor efficacy of intratumoral CD8 + T cell. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-003100.","journal-title":"J Immunother Cancer"},{"key":"2309_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003329","author":"R Muthuswamy","year":"2021","unstructured":"Muthuswamy R, McGray AR, Battaglia S, He W, Miliotto A, Eppolito C, et al. CXCR6 by increasing retention of memory CD8 + T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-003329.","journal-title":"J Immunother Cancer"},{"key":"2309_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/nri1083","author":"J Lieberman","year":"2003","unstructured":"Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol. 2003. https:\/\/doi.org\/10.1038\/nri1083.","journal-title":"Nat Rev Immunol"},{"key":"2309_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0257-x","author":"GV Sharonov","year":"2020","unstructured":"Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-019-0257-x.","journal-title":"Nat Rev Immunol"},{"key":"2309_CR37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-015603","author":"SM Downs-Canner","year":"2022","unstructured":"Downs-Canner SM, Meier J, Vincent BG, Serody JS. B cell function in the tumor microenvironment. Annu Rev Immunol. 2022. https:\/\/doi.org\/10.1146\/annurev-immunol-101220-015603.","journal-title":"Annu Rev Immunol"},{"key":"2309_CR38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4316","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer Res. 2011. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4316.","journal-title":"Cancer Res"},{"key":"2309_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0134-x","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020. https:\/\/doi.org\/10.1038\/s41392-020-0134-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2309_CR40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3292","author":"A Dongre","year":"2017","unstructured":"Dongre A, Rashidian M, Reinhardt F, Bagnato A, Keckesova Z, Ploegh HL, et al. Epithelial-to-mesenchymal transition contributes to immunosuppression in breast carcinomas. Cancer Res. 2017. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3292.","journal-title":"Cancer Res"},{"key":"2309_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5698","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J, et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.5698.","journal-title":"Cancer Med"},{"key":"2309_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610303","author":"V Salemme","year":"2021","unstructured":"Salemme V, Centonze G, Cavallo F, Defilippi P, Conti L. The crosstalk between tumor cells and the immune microenvironment in Breast Cancer: implications for immunotherapy. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.610303.","journal-title":"Front Oncol"},{"key":"2309_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04151-1","author":"F Long","year":"2023","unstructured":"Long F, Wang W, Li S, Wang B, Hu X, Wang J, et al. The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in Bladder Cancer. J Transl Med. 2023. https:\/\/doi.org\/10.1186\/s12967-023-04151-1.","journal-title":"J Transl Med"},{"key":"2309_CR44","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2016017387","author":"AY Mah","year":"2016","unstructured":"Mah AY, Cooper MA. Metabolic regulation of natural killer cell IFN-\u03b3 production. Crit Rev Immunol. 2016. https:\/\/doi.org\/10.1615\/CritRevImmunol.2016017387.","journal-title":"Crit Rev Immunol"},{"issue":"3\u20134","key":"2309_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18632\/genesandcancer.40","volume":"6","author":"A Shvartsur","year":"2015","unstructured":"Shvartsur A, Bonavida B. Trop2 and its overexpression in cancers: Regulation and clinical\/therapeutic implications. Genes Cancer. 2015. https:\/\/doi.org\/10.18632\/genesandcancer.40.","journal-title":"Genes Cancer"},{"key":"2309_CR46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485","author":"A Bardia","year":"2021","unstructured":"Bardia A, Hurvitz SA, Tolaney SM, Loirat D, Punie K, Oliveira M, et al. Sacituzumab Govitecan in metastatic Triple-Negative Breast Cancer. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2028485.","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02309-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:09:33Z","timestamp":1784196573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02309-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2309"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02309-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research involving animals was carried out in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) and the Dartmouth College Committee on Animal Care.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have consented to the publication of this article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}